Credit rating agency, CRISIL has assigned rating of ‘AA/Stable’ to Jubilant Life Sciences’ Non-Convertible Debentures (NCDs) worth Rs 350 crore. The rating agency has reaffirmed rating of ‘A1+’ assigned to the company’s Commercial Paper (CP) worth Rs 400 crore.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.